4//SEC Filing
Stone Christopher Lewis 4
Accession 0000882104-20-000211
CIK 0000882104other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:49 PM ET
Size
4.6 KB
Accession
0000882104-20-000211
Insider Transaction Report
Form 4
Stone Christopher Lewis
VP and General Counsel
Transactions
- Sale
Common stock
2020-12-16$2.56/sh−200,000$512,000→ 405,559 total
Documents
Issuer
PDL BIOPHARMA, INC.
CIK 0000882104
Entity typeother
Related Parties
1- filerCIK 0001453373
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 4:49 PM ET
- Size
- 4.6 KB